Fabunan Antiviral Injection: Difference between revisions
CSV import |
CSV import |
||
| Line 27: | Line 27: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 11:46, 17 March 2025
Fabunan Antiviral Injection is a pharmaceutical drug that has been claimed to have antiviral properties. It is named after its developers, the Fabunan brothers, who are medical practitioners in the Philippines. The injection has been controversial due to a lack of scientific evidence supporting its efficacy and safety.
History[edit]
The Fabunan Antiviral Injection was developed by the Fabunan brothers, who are medical practitioners in the Philippines. The brothers claim that the injection has antiviral properties and can be used to treat a variety of viral diseases, including dengue, hepatitis, and COVID-19. However, these claims have not been scientifically validated.
Composition[edit]
The exact composition of the Fabunan Antiviral Injection is not publicly disclosed. However, it is known to contain a mixture of steroids, anti-inflammatory drugs, and vitamins. The Fabunan brothers have stated that the injection's antiviral properties come from this unique combination of ingredients.
Controversy[edit]
The Fabunan Antiviral Injection has been the subject of controversy due to a lack of scientific evidence supporting its efficacy and safety. The Food and Drug Administration of the Philippines has issued warnings against the use of the injection, stating that it has not been approved for the treatment of any disease. Despite this, the injection continues to be used by some individuals in the Philippines.
See also[edit]
References[edit]
<references />
